According to the research report titled ‘Global Veterinary Medicines Market 2019-2028’, available with Market Study Report, global veterinary medicines market is projected to register a y-o-y growth rate of 4.11% during 2019-2028.
 

The growth of global veterinary medicines market is credited to factors like increased production of livestock products, rise in various diseases in animals, and growing ownership of pets. Moreover, surging expenditure for animal healthcare and emphasis on veterinary specialization are generating lucrative prospects for the business scenario.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3552564/
 

However, negative effects post-vaccination and lack of expert veterinarians are the factors restraining the market progression.
 

Based on animal type, worldwide veterinary medicines industry is segmented into companion animals, and livestock animals. On the basis of distribution channel, the marketplace is divided into veterinary hospital pharmacies, and retail veterinary pharmacies. Speaking of route of administration, the industry space is classified into parenteral route, topical route, and oral route. Moving on to product range, the market is categorized into vaccines, drugs, and medicated feed additives.
 

Considering the geographical analysis, global veterinary medicines industry size spans across North America, Latin America, Middle East & Africa, Europe, and Asia-Pacific. The report encompasses an in-depth analysis of the current and predicted sizes of these markets to assist stakeholders to identify the top business opportunities for the upcoming years.
 

Expert analysts cite that Asia-Pacific market is likely to exhibit remunerative growth over the forecast period, owing to high investments in research & development, along with efforts for commercializing veterinary pharmaceuticals and vaccines at a nominal cost. In addition to this, the need to manage disease outbreaks and control the increasing prevalence of zoonotic disease are augmenting the market outlook.
 

Leading players in worldwide veterinary medicines industry sphere are Virbac S.A., Ceva Santé Animale, Archer-Daniels-Midland Company (ADM), Vetoquinol .SA., Biogenesis Bago S.A., Zoetis Inc., Merck & Co. Inc., Boehringer Ingelheim Animal Health GmbH, Indian Immunologicals Limited,  Evonik Industries AG, Kindred Biosciences, Hester Biosciences Limited, Elanco Animal Health Incorporated, Neogen Corporation, and Dechra Pharmaceuticals PLC.